Our findings in the ovarian cancer patient samples corroborate recently reported finding that NANOG potentiates chemoresistance and EMT in ovarian cancer cells, even though in this case it was shown to be acting through signal transducer and activator of transcription 3 (STAT3) [12]. The gene discussed is STAT3; the disease is ovarian cancer.